Halma delivers record first-half revenue of £1.43bn as adjusted profit rises 22.5%

HLMA

Halma plc (LON:HLMA), the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, has announced its results for the 6 months to 30 September 2026.

Halma’s results, together with other information about Halma, will be available on its corporate website, www.halma.com, and the results have been submitted in full unedited text to the Financial Conduct Authority’s National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

The webcast of the results presentation will be available on the Halma website later today: www.halma.com

Dividends

The Board has proposed a 7% increase in the interim dividend to 10.30p per share (2025/26: 9.63p per share). This will be paid on 29 January 2027 to shareholders on the register on 18 December 2026.

The Company offers a Dividend Reinvestment Plan (‘DRIP’) to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish to opt for the DRIP for the forthcoming final dividend should return a DRIP mandate form to the Company’s Registrar no later than 8 January 2027.

Financial calendar

Ex-dividend date for 2026/27 interim dividendThursday 17 December 2026
Record date for 2026/27 interim dividendFriday 18 December 2026
Final date for DRIP electionFriday 8 January 2027
Payment dateFriday 29 January 2027
Share on:

Latest Company News

Halma delivers record first-half revenue of £1.43bn as adjusted profit rises 22.5%

Halma has reported a 15.8% increase in first-half revenue to £1.43bn for the six months ended 30 September 2026,...

Halma raises profit margin guidance after strong first half

Halma expects a 23.5%–24% Adjusted EBIT margin for 2027 after strong first-half growth and £515m of acquisitions....

Halma to acquire water quality monitoring specialist Pyxis for $170m

Halma has agreed to acquire Pyxis, a US-based provider of water quality monitoring and analysis technology, for an initial...

Halma completes sale of NovaBone for $60m

Halma has completed the sale of NovaBone Products LLC and its subsidiaries to Isto Biologics for total consideration of...

Halma expands healthcare portfolio with Dreampath acquisition

Halma has announced the acquisition of Dreampath, adding tissue sample traceability and storage capabilities to its Healthcare Sector....

Halma reports full-year results and proposes higher final dividend

Halma has released full-year results for the year to 31 March 2026 and proposed a higher final dividend....

    Search